Data investigation

What Makes a Telehealth GLP-1 Prescription Legitimate

The FDA publishes seven warning signs for telehealth medicine sellers. Here they are, with what proper prescribing looks like and the one disclosure that 139 of our 560 sellers failed in an August 2026 count.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed
7 min read·1 citation

A growing share of GLP-1 prescriptions in the United States now start on a website. That is not a problem in itself; telehealth prescribing is ordinary, legal medicine. What varies enormously is how much medicine actually takes place. The FDA publishes its own list of warning signs for exactly this situation, and it is a sharper checklist than most of what gets written about buying online.[1]

The FDA's own red flags

These are the agency’s, not ours. It tells consumers to look out for a company that:[1]

  • claims the compounded drug is the same as an FDA-approved drug
  • offers medicine at deep discounts, or prices that seem too good to be true
  • sends medicine that looks different from what you previously received or what was pictured on the site, or that arrives in broken or damaged packaging, or without instructions for use
  • does not require a screening and prescription by a licensed doctor before providing medicine
  • has no licensed doctor available to answer questions after you receive the medication
  • makes spelling errors on the label, or gives an incorrect address for the pharmacy
  • puts a pharmacy name on the label that you suspect is fraudulent

Two of those deserve pulling out, because they describe the whole business model of the worst operators rather than a slip. A service that does not require screening and a prescription from a licensed doctor is not a fast telehealth service; it is not prescribing at all. And a service with no doctor reachable after delivery has sold you a product rather than provided care, and that gap matters most at the moment something goes wrong.

What good prescribing looks like

The FDA’s baseline is simple to state: compounded drugs should only be used by patients whose medical needs cannot be met by an FDA-approved drug, patients should obtain a prescription from their doctor, and should fill it at a state-licensed pharmacy.[1] Everything below follows from that.

  1. A licensed clinician evaluates you before anything is prescribed. The format (video, phone or a written exchange) is set by state law and varies; whether an evaluation happens at all does not.
  2. That clinician is licensed in your state, not merely somewhere. This is the requirement most often quietly missing, and the one a buyer can rarely verify from the outside.
  3. The intake asks questions that could change the answer. A form that cannot produce a ‘no’ is not a screening. Thyroid cancer in the family, MEN 2, a pancreatitis history, pregnancy and whatever else you take all belong in it.
  4. A named pharmacy dispenses it. A name you can look up, not “a licensed US compounding pharmacy”.
  5. Someone is reachable afterward. Dose changes, side effects and the decision to stop are all clinical events, and they all happen after the first shipment.
Platform or prescriber? Read the footer. A great many sites state plainly that they do not practice medicine, do not write prescriptions and do not dispense; they connect you to independent providers and pharmacies. That disclosure is accurate, and it matters: it tells you who is responsible when something goes wrong, and it is usually not the brand whose name is on the box. LongevityFix MD’s terms, for example, describe a patient management platform that works with independent physicians, and its telehealth consent names Stealth Medical Group PA as the practice. At Embody, the clinician who decides on a compounded semaglutide or tirzepatide prescription comes from OpenLoop Health, and that decision comes after you pay at checkout.

Beluga Health shows how that structure works from the other side: it is a physician-led group that describes itself as the clinical engine behind hundreds of brands, supplying their prescribers and pharmacy routing, and its partner pharmacies are not named. Blackout Medical, a Utah seller of a compounded GLP-1 injection, is one of those brands: its telehealth consent describes visits with a Beluga practitioner through the Bask Health platform, and its site names no pharmacy beyond “a licensed U.S. pharmacy.” At the other end are sellers where the prescriber is the brand. Potere Health MD is a Utah clinic whose named physician sees patients in person or by telehealth within the state, MD Trim Clinic names its physician and nurse practitioner and has offices in California and Arizona, and Mevo Health names the four board-certified physicians who deliver its care.

Smaller practices put the clinician up front as well. Northern Colorado Medical, a Fort Collins practice that treats adults in Colorado only, names one Colorado-licensed family physician for every evaluation and prescription. Olivera Weight Loss in Chicago was founded by a board-certified gastroenterologist and prescribes by phone to Illinois residents. Spartan Medical Associates names two board-certified physicians at its Charlotte and Huntersville offices and sees patients in person or by telehealth anywhere in North Carolina. Invite Wellness is run by a board-certified nurse practitioner in Maryland who prescribes over video visits in 14 states. Base1 Health books Texas patients with a physician-owned practice in Benbrook, where the doctor reviews your blood work and meets you by video before deciding whether to prescribe.

A name is the start of the check, not the end of it. Gentle Health names one physician, who prescribes for every patient in the 40 states and DC it serves. At Tactus Health, the medical director is a nurse practitioner identified by first name only. North Carolina Trim Clinic describes its visit as a phone call on one page and a video visit on another, and its terms call the site a marketing and referral platform.

On the first point in the list, Factor Health MD and Medical Health Institute both require a video visit with a provider before anything is prescribed. Amble works the other way. It relies on the online review in most states and adds a short video or phone call only where state rules require one. A seal is a separate check from any of this: FeelGood and Unique Physique list LegitScript verification for themselves and Lumora lists LegitScript certification, while Potere Health MD and MD Trim Clinic describe the pharmacy they use as LegitScript-certified, which is a claim about the pharmacy rather than the seller.

REGENX Health, a Houston men’s clinic, holds every visit by video with a board-certified urologist. Aspire Health MN makes the first visit live, by video or in its office, with no asynchronous option. At Restore Hyper Wellness studios, a GLP-1 plan starts with a telemedicine consult with a nurse, followed by a nurse practitioner by telemed. Kingsberg Medical has no online intake: you send a contact form or call, and the first consultation, which can be virtual, is free. Wellis works the other way, by online questionnaire, adding a video or phone visit only where your state or the clinician calls for one.

The disclosure gap we can measure

When we counted in August 2026, 139 of the 560 sellers then in our register carried a note from our reviewer that the compounding pharmacy is not named anywhere on the site. That is a floor rather than a total, because it counts only the records where someone wrote it down. It is also the single most common disclosure failure we record.

It matters more than it looks, because the pharmacy is who made the thing you inject. Without a name there is no state license to check, no inspection history, and no way to act on the FDA’s advice to contact the compounder with questions.[1] It also makes the label-fraud problem unanswerable from your side, which we cover in is the vial you received what the label says.

139 of 560 sellers did not name their compounding pharmacy anywhere on their site.

Ask which pharmacy, directly and in writing, before you buy. A seller that answers plainly has told you something good about itself. A seller that will not is telling you something too. Our comparison tool filters on what each one discloses.

Where to check things yourself

  • The FDA’s BeSafeRx campaign is the agency’s own resource for buying prescription medicines online safely, and it is the first place to send anyone who is unsure.[1]
  • Your state board of pharmacy holds the license record for any pharmacy that names itself.
  • Your state medical board holds the license record for a named prescriber, including whether it covers your state. The name is the part to get first: New Tides says its physician is licensed in 45 states and Washington, D.C., and that licensure can be verified through each state board’s lookup, but it does not name the physician.
  • The seller itself. The FDA specifically suggests contacting the compounder or the telehealth platform you bought from with questions about the label or instructions for use.[1]
None of this is a reason to avoid telehealth. Distance care is how a great many people get treatment they would otherwise not get at all, and for most readers the alternative would be no clinic. The checks above take about ten minutes, and they are the difference between telehealth and a storefront.

Frequently Asked Questions

Yes. Telehealth prescribing is ordinary medicine, subject to state law. What must happen is that a clinician licensed in your state evaluates you before prescribing, and that the prescription is filled at a state-licensed pharmacy. The format of the evaluation varies by state; the existence of one does not.
The agency lists seven: claiming a compounded drug is the same as an FDA-approved one; deep discounts or prices too good to be true; medicine that looks different from what was pictured or arrives damaged or without instructions; no screening and prescription by a licensed doctor; no doctor reachable after delivery; spelling errors or a wrong pharmacy address on the label; and a pharmacy name that looks fraudulent.
It can, depending on the state and on the questionnaire. The practical test is whether the form could produce a refusal: whether it asks about medullary thyroid carcinoma and MEN 2 in the family, a pancreatitis history, pregnancy and your current medications, and whether a clinician reads the answers. A form that cannot say no is not a screening.
Because that is who made what you inject. Without a name there is no license to check and no inspection history to look at, and you cannot follow the FDA's advice to contact the compounder with questions. In our August 2026 count, 139 of 560 sellers had a note that the pharmacy is not named, the most common disclosure failure we record.
Not by itself. It is usually an accurate description of a platform that connects you to independent clinicians and pharmacies. Read it carefully, though, because it tells you who carries responsibility if something goes wrong, and that is generally not the brand on the box.

References

  1. 1.U.S. Food and Drug Administration. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — drug alert, including telehealth red flags for consumers; content current as of October 1, 2026 FDA. 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss

Who Actually Runs Your GLP-1 Brand

At our August 2026 count, 61 of the 560 sellers we tracked named one of just seven shared entities: one white-label platform, two prescriber networks, four compounding pharmacies. Comparing two brands can mean comparing two markups on the same vial.

7 min read

Microdosing a GLP-1: What Evidence Exists

In August 2026, 62 of the 560 sellers we tracked offered a microdose product. The published literature is letters and commentary about how to answer patients who ask for it; we identified no randomized trial.

6 min read

What a LegitScript Badge Tells You, and What It Doesn't

LegitScript certification is real, and it is also a paid commercial service that unlocks Google and Meta ads and payment processing. The badge on a seller's page is an image. This shows how to confirm one, and why 182 of our own records were unverified at our August 2026 count.

7 min read

The GLP-1 Terms You Agree To at Checkout

Four sellers ask you to waive the right to your own pharmacy. Twenty-four keep the consult fee whatever happens. What the terms pages said across 560 sellers in August 2026, and the one question to ask before paying.

6 min read

How to Check a Seller's Review Score in 60 Seconds

One seller's homepage showed a Trustpilot badge reading 4.8/5. Trustpilot had no page for its domain, and a company search returned 138 results without it. The method takes a minute, and it works both ways.

6 min read

What 519 GLP-1 Signup Funnels Look Like

Thirty percent of GLP-1 sellers show no price until you have completed a medical intake. A majority publish no list of the states they serve. What the signup pages of 519 sellers reveal.

7 min read

Where to get GLP-1 online, safely: sellers our editors have checked

These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

9.0

YourEra

Semaglutide at $99/month, well below the typical price

7.4

Wellorithm

Compounded semaglutide at a flat $247 every 28 days, any dose

8.5

Gala

Moving between compounded and brand without changing seller

About this analysis

GLP Watchdog publishes independently. Each seller in our dataset is checked against that seller's own website, and the dataset is updated continuously. Read our full methodology →